Telix Pharmaceuticals (T3X.F) Q1 2022 Earnings

24JanConfirmed
Q3 2020
Q1 2021
Q3 2021
Q1 2022
-0.11
-0.09
-0.06
-0.04

Details

Expected EPS
N/A
Actual EPS
-0.10739438799274696
Surprise EPS
-0.11
Surprise Percent
+∞%

Description

Telix Pharmaceuticals (T3X.F) has reported earnings of -0.10739438799274696 per share for Q1 2022.

0 Comments

Share your thoughts